Life Sciences transaction advisory
Focused mandates
Disciplined execution
PMC advises owners, companies and investors on selected sell-side, buy-side, licensing, partnering and capital situations – confidentially and with one clear route from objective to decision.
Mandate first
Start with the transaction objective – not a catalogue of services
Each mandate is assembled around the desired outcome, the parties involved and the required level of confidentiality. PMC then combines the relevant research, positioning, outreach, process and transaction support.
Core mandates
Three routes cover the principal transaction situations
The scope may be narrow or end-to-end. PMC remains focused on relevance, controlled communication and a practical next step.
Company, portfolio and asset transactions
Positioning, valuation context, teaser and CIM preparation, buyer mapping, discreet outreach, qualification and support through NBO, LOI and closing.
Explore sell-side advisory →Target search and proprietary origination
Acquisition criteria, market and target mapping, screening, confidential approach, owner dialogue, qualification and support around a concrete transaction.
Explore buy-side advisory →Licensing, partnering, investors and capital
Product and portfolio opportunities, regional rights, commercial partnerships, growth capital, minority investment, platform situations and selected exits.
Discuss the situation →Applied as required
The specialist capabilities behind the mandate
Not every engagement needs every workstream. The relevant elements are selected, sequenced and documented for the specific transaction.
Strategic framing & positioning
Objective, transaction perimeter, investment rationale, value drivers and market narrative.
Research, mapping & matching
Buyers, targets, investors, licensees, distributors and strategic partners.
Materials & confidential process
Teaser, CIM, selected supporting documents, agreement control and protected Deal Room release.
Dialogue, negotiation & decision
Qualified calls, Q&A, indications of interest, NBO, LOI, negotiation and closing support.
Controlled execution
One clear process from mandate to transaction decision
Confidential information is released selectively. Interest, agreements, access and next actions remain separate and traceable throughout the process.
How PMC works- 01
Define
Clarify objective, scope, decision-makers, confidentiality and timeline.
- 02
Position
Prepare the transaction logic, materials and qualified counterparty universe.
- 03
Approach & qualify
Conduct selected outreach and move credible interest into controlled dialogue.
- 04
Negotiate & conclude
Support review, NBO, LOI, negotiation, documentation and closing preparation.
Why PMC
Specialist reach without unnecessary market noise
PMC combines Life Sciences sector focus with a controlled transaction platform and personal senior-level execution.
Life Sciences specialisation
Pharma, Biotech, Consumer Health, MedTech, Diagnostics, Healthcare Services and related technologies.
Confidentiality by design
Public positioning, confidential disclosure, agreements, approvals and Deal Room access are handled step by step.
A defined next action
Every credible dialogue moves toward a call, further information, an offer, further review or a documented conclusion.
A focused first conversation
Tell us what you want to achieve
PMC will assess the objective and suggest the most appropriate mandate route.
